BGF (formerly Business Growth Fund) is a London-based private equity and growth capital firm established in 2011, providing patient, minority equity investment to small and mid-sized businesses across the UK and Ireland. It has deployed more than £4.5bn of growth capital and is a certified B Corporation.
Deal activity decreased year-over-year (5 deals in the last 12 months vs 10 prior). Average disclosed round size is $26.6M (across 44 rounds with reported amounts).
Portfolio
79
Fund Size
—
Top Stage
Unknown
Last 12 Mo
4
Team
Anita Dougall
Non-Executive Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
89 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Luffy AI | Series A | — | Jul 2026 |
| FFivium | Unknown | — | Apr 2026 |
| TTMT ID | Growth | — | Nov 2025 |
| EEnhanced Genomics | Series A | — | Sep 2025 |
| CCyted Health | Series B | $44M | Sep 2025 |
 Cronofy | Growth | $19.1M | May 2025 |
 Phlux | Series A | $10.7M | Mar 2025 |
 Maxion Therapeutics | Series A | $72M | Mar 2025 |
 TRIMTECH Therapeutics | Seed | $14M | Mar 2025 |
 Cambridge GaN Devices | Series C | — | Feb 2025 |
 OrganOx | Unknown | $142M | Jan 2025 |
 DEScycle | Series A | — | Nov 2024 |
 Forefront RF | Series A | $20M | Nov 2024 |
 NanoSyrinx | Unknown | $12.7M | Sep 2024 |
 Sunswap | Unknown | — | Aug 2024 |
 Gaussion | Series A | — | Aug 2024 |
 Echion Technologies | Series B | $35M | Jun 2024 |
| AAction24 | Growth | — | Apr 2024 |
 Wobble Genomics | Unknown | — | Mar 2024 |
| Maxion Therapeutics | Series A | $16M | Feb 2024 |
 Fluorok | Unknown | $7.7M | Jan 2024 |
 ViaNautis | Series A | $25M | Nov 2023 |
| MMachine Discovery | Seed | — | Sep 2023 |
 Nuada | Series A | — | Jul 2023 |
 Caristo Diagnostics | Series A | $16.3M | Apr 2023 |
Page 1 of 4
Top Co-Investors
Octopus Ventures11 shared
Eli Lilly and Company5 shared
Foresight Ventures4 shared
LifeArc Ventures4 shared
IQ Capital4 shared
Parkwalk Advisors4 shared
Gresham House3 shared
Kindred Ventures3 shared
Heartcore Capital3 shared
Phoenix Court Group3 shared
Monograph Capital3 shared
British Patient Capital3 shared
MMC Ventures3 shared
Clean Growth Fund3 shared
IP Group plc3 shared
Cambridge Innovation Capital3 shared
Barclays3 shared
Volta Energy Technologies3 shared
Cambridge Enterprise3 shared
Last updated: 7 September 2026